Live recombinant vector vaccines for veterinary use - Scientific guideline

Scientific guidelineVeterinaryScientific guidelines

Finnish is available via eTranslation, the European Commission's machine translation service.

Translate to Finnish | Important information about machine translation

This guidelines provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Keywords: Live, recombinant vector vaccine, veterinary

Current version

Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Adopted Reference Number: EMA/CVMP/IWP/390313/2023 Legal effective date:

English (EN) (224.05 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä

Revision 1

Draft guideline on live recombinant vector vaccines for veterinary use - Revision 1

Draft: consultation closed Consultation dates: to Reference Number: EMA/CVMP/IWP/390313/2023 Summary:

This guideline provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Comments should be provided using this template. The completed comments form should be sent IWP@ema.europa.eu

English (EN) (236.82 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä

Overview of comments received on Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Reference Number: EMA/260063/2024

English (EN) (174.68 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä

First version

Guideline on live recombinant vector vaccines for veterinary use

Adopted Reference Number: EMEA/CVMP/004/04-FINAL Legal effective date:

English (EN) (49.66 KB - PDF)

Julkaistu ensimmäisen kerran: Viimeksi päivitetty:
Näytä

Concept paper for the revision of the guideline on live recombinant vector vaccines for veterinary use

Draft: consultation closed Consultation dates: to Reference Number: EMA/CVMP/IWP/161133/2023

English (EN) (158.52 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä

Share this page